SCHEMBL3974458

SCHEMBL3974458

Cn1nc(NC(=O)O)cc1-c1cncc(Br)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.40
NPC1 O15118 6/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 2/20 0.38
HCAR2 Q8TDS4 1/20 0.37
GRM5 P41594 1/20 0.37
LMNA P02545 2/20 0.37
ALDH1A1 P00352 1/20 0.37
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
CYP11B2 P19099 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 3/20 0.35
CYP2A6 P11509 1/20 0.35
PKM P14618 1/20 0.34
ALOX15 P16050 1/20 0.33
CASP3 P42574 1/20 0.33
TNIK Q9UKE5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972288 0.89 PTGS2 (0.38) RAB9ANPC1KMT2APOLBHCAR2
SCHEMBL3971543 0.79 POLB (0.44) KMT2APOLBHCAR2GRM5ALDH1A1
SCHEMBL31200322 0.76 CYP2A6 (0.41) RAB9ANPC1POLBHCAR2ALDH1A1
SCHEMBL3972438 0.76 MMP2 (0.44) KMT2ASMN1; SMN2CYP2A6
SCHEMBL3972385 0.73 ADORA2A (0.37) KMT2ALMNAALDH1A1KDM4E
SCHEMBL22445427 0.73 LMNA (0.46) RAB9ANPC1KMT2APOLBLMNA
SCHEMBL3970935 0.72 CYP11B2 (0.38) POLBHCAR2ALDH1A1KDM4ECYP11B2
SCHEMBL4518431 0.72 POLB (0.34) RAB9ANPC1POLBHCAR2SMN1; SMN2
SCHEMBL25410263 0.69 LMNA (0.49) KMT2APOLBLMNAALDH1A1KDM4E
SCHEMBL4508178 0.69 PIP4K2A (0.48) CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016068-A1 PYRAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS AstraZeneca AB (SE) 2009-01-21 EP disclosed
WO-2007129052-A1 PYRAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS ASTRAZENECA AB (SE) 2007-11-15 WO disclosed